Effect of trastuzumab/AT-101 combination on apoptosis and cytotoxicity in HER2-positive breast cancer cells: A novel combination to effect resistance to anti-HER2 therapy through inhibition of PI3K signaling.

Simple item page
dc.contributor.authorKaraca, B
dc.contributor.authorBozkurt, E
dc.contributor.authorAtmaca, R
dc.contributor.authorSurmeli, Z
dc.contributor.authorPinar, A
dc.contributor.authorSanil, UA
dc.contributor.authorUslu, R
dc.date.accessioned2025-04-10T10:31:57Z
dc.date.available2025-04-10T10:31:57Z
dc.identifier.e-issn1527-7755
dc.identifier.issn0732-183X
dc.identifier.urihttp://hdl.handle.net/20.500.14701/38393
dc.language.isoEnglish
dc.titleEffect of trastuzumab/AT-101 combination on apoptosis and cytotoxicity in HER2-positive breast cancer cells: A novel combination to effect resistance to anti-HER2 therapy through inhibition of PI3K signaling.
dc.typeMeeting Abstract

Files

Collections

Web of Science Koleksiyonu